| abstract |
REFERS TO A COMPOUND USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES SUCH AS BRAIN APOPLEJIA AND CRANIAL-ENCEPHALIC INJURY, FORMULA I R1-ADEGL-R2, WHERE R1 MAY BE A RESIDENT OF ARILO C6-C10, QUINO : 1, 2, 3, 4, 5, 6, or 7, WHERE IS 1 or 2, R3 MAY BE H, C2-C6 ALKYLENE, C1-C6 ALKYL OR RING, THESE RING AND REMAINING SYSTEMS MAY BE REPLACED BY: HALOGEN, CARBOXYL, HYDROXYL, PHENYL, ALCOXY or ALCOXYCARBONYL C1-C6, ALKYL C1-C8, ALKYL SULFONYLOXI C1-C6, AZIDO, AMINO, MONO or DI ALKYLAMINE C1-C6, ONE GROUP OF-BULD - COUL b MAY BE 0 or 1, R4 AND R5 MAY BE H, PHENYL, ACIL C1-C6, CYCLOACE C4-C7, BENZOIL OR C1-C6 ALKYL SUBSTITUTED BY AMINO, MONKEY OR DI C1-C6 ALKYLAMINE, A GROUP OF FORMULA -NR6 -SO2-R7, WHERE R6 MAY BE: H, PHENYL, ALKYL or C1-C6 ACIL, R7 MAY BE: PHENYL or C1-C6 ALKYL; A AND E MAY BE THE SAME OR DIFFERENT AND REPRESENT A LINK or C1-C4 ALKYLENE; D MAY BE OXYGEN or REST OF FORMULA -S (O) c- or -N (R9) -, WHERE c MAY BE 0, 1 or 2, R9 MAY BE: H, ALKYL or ACIL C1-C6; G IS A SUBSTITUTED ARYL GROUP C1-C6; L MAY BE -O-, -NH-, OR SULPHONAMID COMPOUNDS; R2 MAY BE PHENYL, NAPHTHYL, PIRIDYL, FURYL, TENYL or PYRIMIDYL |